【摘 要】
:
Aim: To observe differences between Herba Ephedrae and Fructus Schisandrae on the angiogenesis for treating rat idiopathic pulmonary fibrosis induced by bleomycin. Methods: The rats were modeled by bl
【机 构】
:
School of Chinese Materia, Beijing University of Chinese Medicine, BUCM Beijing, China
【出 处】
:
第十一届全国青年药学工作者最新科研成果交流会
论文部分内容阅读
Aim: To observe differences between Herba Ephedrae and Fructus Schisandrae on the angiogenesis for treating rat idiopathic pulmonary fibrosis induced by bleomycin. Methods: The rats were modeled by bleomycin, which divided into six groups to drug administration, ephedra alone, schisandra alone , the combination of the two drugs, hydrocortisone alone for 28 days. 7d and 28d, the rats were killed respectively for Pathological morphology examination microvascular density examination, Angiogenesis-related cytokines examination. Results: Both the Ephedra group and the hydrocortisone group had statistically significant on restraining the alveolitis grades and pulmonary fibrosis (P<0. 05) . The number of the blood vessel of the Ephedra group is higher than the Schisandra group and combination therapy group. At 7d, the level of ET-1 of the model group was at a higher level , and had more significant difference with the normal group (P<0. 01) .The level of 6-Keto-PGF1α of the treatment group rised, and there was significant difference between Ephedra, and combination therapy group and the normal group (P <0. 05) . Conclusion: Ephedra has positive effect on restrain the increase of Lung Coefficient. Combination therapy group can significantly restrain the pulmonary artery injury and can also restrain the angiogenesis of the arteries by reducing the level of ET-1 and promoting the level of 6-Keto-PGF1α in blood. Both Ephedra and schisandra can restrain alveolitis and the development of pulmonary fibrosis.
其他文献
小叶黑柴胡总黄酮有显著的退黄利胆功效,而其如何在机体内发挥作用,目前尚未见报道。本文通过代谢组学方法对小叶黑柴胡总黄酮防治α-萘异硫氰酸酯(α-naphtyl isothiocy,ANIT)所致大鼠急性黄疸型肝损伤过程中的尿液代谢组进行研究,从而探讨小叶黑柴胡总黄酮对急性黄疸型肝损伤的防治效果及作用机制。结果显示,给药组和模型组相比,大鼠尿液代谢物中马尿酸、庚酰肉毒碱、5 β-胆甾烷-3 α,7α
目的:通过聚乙二醇(PEG)将寡核苷酸适配体(Aptamer,APT)和聚酰胺-胺(PAMAM)连接,合成新型的前列腺癌靶向基因载体PAMAbt-PEG-APT,提高基因的转染效率和前列腺癌细胞靶向性。方法:运用NMR法鉴定合成的PAMAM-PEG-A10载体的结构,在前列腺癌细胞(PC3和LNCaP)上进行摄取实验和基因转染实验考察载体的生物学性质。结果:通过结构鉴定确定PAMAM-PEG-A1
药物耐受是导致肿瘤化疗失败的主要因素,其中药物多药耐受转运体糖蛋白(P-glycoprotein,P-gp)的过度表达是造成肿瘤多药耐药的最主要机制,也是逆转多药耐药的最主要靶点。通过抑制或调节转运体蛋白的活性,从而增加药物在靶组织的有效浓度,是提高药物对肿瘤治疗效果的一项重要措施。为了研究纳米制剂对P糖蛋白介导多药耐药的逆转作用,本研究合成了具有较大载药量的羧基功能化介孔二氧化硅纳米粒,并研究了
目的:合成、鉴定G3.0 PAMAM-LED209分子,并在体外评价其抗菌特性。方法:合成目标分子并通过1H-NMR、13C NMR及元素分析进行结构表征;分别通过MIC和MTT方法评价G3.0 PAMAM-LED209抗菌活性和细胞毒性;通过PCR法检测G3.0 PAMAM-LED209对出血性大肠杆菌EHEC致病基因表达的影响。结果:通过1H NMR和13C NMR分析得知,meta-LED2
目的:建立蝎毒镇痛活性肽BmK AngM1在毕赤酵母中的高水平表达系统。方法:根据BmK AngM1的cDNA序列,结合毕赤酵母的密码子偏爱性,合成BmK AngM1基因。将BmK AngM1基因克隆到表达载体pPIC9K中,转化毕赤酵母,甲醇诱导表达。通过Ni2+螯和层析和HPLC建立重组蛋白rBmK AngM1的纯化方法。通过小鼠扭体镇痛实验模型对rBmK AngM1进行药理活性评价。采用单因
目的:研究盐酸阿霉素壳聚糖纳米粒(adriamycinhy drochloride chitosan nanoparticles,ADM-CS-NPs)大鼠鼻腔给药后的脑内药动学特征。方法:以壳聚糖为载体材料,采用离子交联法制备ADM-CS-NPs。以清醒自由活动大鼠为实验动物模型,采用脑微透析取样技术,连续收集ADM-CS-NPs及阿霉素溶液剂经鼻腔给药与静脉注射给药后大鼠海马部位透析液,HPL
目的:研究11个不同批次的当归、枳壳经CO2超临界混合萃取的挥发油的高效液相色谱指纹图谱,为科学评价和有效控制其质量提供实验依据。方法:色谱条件:伊力特ODSC18(250×4.6mm,5 μm)色谱柱,乙腈-水为流动相,梯度洗脱,柱温30℃,流速1 mL/min,检测波长为325 nm。结果:本研究建立了11个不同批次的当归、枳壳混合提取的挥发油的指纹图谱,以蒿本内酯为参照峰,共标定了13个共有
Herbal injection is one of the most powerful preparations of modern Traditional Chinese Medicine; however the quality control of it is fairly difficult for their complicated constituents. Recently, ch
目的:研究基于双层压片技术的尼美舒利口服双相释药系统的体内外释放行为。方法:在制备尼美舒利双层片的基础上,对其体外释放和体内药动学行为进行系统考察。结果:所制备的尼美舒利双层片体外具有明显的双相释放特征,和参比制剂尼美舒利分散片相比,自制双层片的Cmax降低,Tmax相当,MRT明显延长,相对生物利用度为100.8%。结论:尼美舒利口服双相释药系统不仅能够快速起效,而且能够缓慢维持药效,实现了速缓
草酸钙肾结石是世界范围的常见病、多发病。通过建立高草酸诱致大鼠肾损伤的肾结石大鼠模型,采用草叶马尾藻多糖(SGP)分别以高剂量(1000mg/kg)、中剂量(500mg/kg)、低剂量(100mg/kg)进行干预治疗。运用组织切片和显微镜等技术观察。肾组织中草酸钙结晶沉积的情况,利用各类相关酶活性测试盒和丙二醛(MDA)测试盒,对大鼠肾组织匀浆过的氧化氢酶(CAT)、谷胱甘肽过氧化物酶(GSH-P